Volume 13 Supplement 1
Proceedings of the 9th Edition of the Scientific Days of the National Institute for Infectious Diseases "Prof Dr Matei Bals"
Meeting abstracts
Edited by Adrian Streinu-Cercel, Vlad Ratziu, Olivier Patey, Victoria Aramă, Monica Luminos, Elisabeta Benea, Mariana Mărdărescu, Alexandru Rafila, Anca Streinu-Cercel, Mihai Săndulescu, Oana Streinu-Cercel and Ana Maria Tudor
The publication of this supplement has been funded by the "Prof Dr Matei Bals" Foundation. The Supplement Editors declare that they have no competing interests.
The 9th Edition of the Scientific Days of the National Institute for Infectious Diseases "Prof Dr Matei Bals". Go to conference site.
Bucharest, Romania23-25 October 2013
Page 1 of 3
-
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O1
-
Postpartum evolution of newborns to mothers addicted to “new drugs” and recently diagnosed with HIV infection
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O2 -
Vaccination of HIV positive children... a genuine challenge
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O3 -
Chatting online – is this good for you?
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O4 -
Can HIV infection during pregnancy cause an intrauterine growth restriction?
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O5 -
Causes of mortality among new HIV-infected intravenous drug users in a clinical hospital in Bucharest
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O6 -
Toxoplasmosis: a rare cause of IRIS in HIV infected patients. Case series
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O7 -
Human immunodeficiency virus coinfection with drug-resistant Mycobacterium tuberculosis
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O8 -
Urinary tract infections during pregnancy – clinical picture and therapeutic approach in the Infectious Diseases Hospital of Iaşi (2009-2012)
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O9 -
Perinatal infections – a permanent challenge
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O10 -
Retrospective study on HIV infected pregnant women and their babies in the Western part of Romania
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O11 -
Promotion of health care workers immunization in Europe – the main objective of the HProImmune project
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O12 -
Microbiological profile and multidrug resistant bacteria in pneumonia
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O13 -
In the era of broad spectrum antibiotics, is ampicillin still an option?
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O14 -
Molecular determinants of resistance in Escherichia coli-ST131 isolated blood stream infections
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O15 -
Antimicrobial resistance of germs isolated from invasive infections – Romania 2012
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O16 -
Antibacterial consumption in Romania in 2012: specific features and quality indicators for community usage
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O17 -
Critical patient disease characteristics
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O18 -
Gut microbiota and its complex role. The experience of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş” in fecal bacteriotherapy for Clostridium difficile infection
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O19 -
Clostridium difficile colitis – a serious current problem
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O20 -
Severity prediction for Clostridium difficile infection with ATLAS score – new data from a less developed country (Romania)
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O21 -
Novel therapeutic options for the emerging infectious diseases from Romania
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O22 -
Do we know the place of systemic corticosteroids in infectious diseases?
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O23 -
HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O24 -
Tuberculosis reactivation during novel, biologic therapy
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O25 -
Lung infections in cardiac transplant recipients
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O26 -
The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O27 -
Cardiovascular impairment in young adults horizontally infected with HIV-1 in childhood
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O28 -
Neurocognitive impairment screening in Romanian HCV infected patients
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O29 -
Metabolic syndrome, insulin resistance and the risk of cardiovascular disease in HIV patients undergoing antiretroviral therapy
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O30 -
Metabolic features in chronic HCV infected patients
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O31 -
Inflammatory patterns in patients with chronic hepatitis C
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O32 -
Correlation between inflammatory biomarkers and metabolic disorders in HIV infected patients undergoing antiretroviral therapy
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O33 -
Pregnancy and birth in HIV seropositive women - present stage results
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O34 -
The role of sonication in the microbiological diagnosis of implant-associated infections – the experience of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O35 -
The evolution of sexually transmitted infections in Romania
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O36 -
The involvement of HPV in cervical oncogenesis
Citation: BMC Infectious Diseases 2013 13(Suppl 1):O37 -
The value of interferon-gamma blood tests for the diagnosis of tuberculosis in HIV patients
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P1 -
Tuberculous meningitis: presentation, diagnostic and outcome in HIV-infected individuals from regional center Iaşi
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P2 -
Particular evolution of newborns exposed to HIV/AIDS in the Romanian cohort
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P3 -
Toxoplasma gondii infection in immunocompromised individuals
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P4 -
Adherence to antiretroviral treatment in 2013 between myth and reality
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P5 -
New cases of HIV/AIDS in adults during 2007-2012
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P6 -
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P7 -
Severe sepsis and cerebral toxoplasmosis in an HIV-infected late presenter patient
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P8 -
Toxoplasma encephalitis in an HIV-positive patient – a case report
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P9 -
Clinical and prognostic features of cerebral toxoplasmosis in HIV infected patients – a case series
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P10 -
Vitamin D levels among HIV-infected patients – peculiar features
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P11 -
Mycobacterium tuberculosis infection in intravenous drug users recently diagnosed with HIV/AIDS
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P12 -
Hepatitis B coinfection in HIV-infected patients
Citation: BMC Infectious Diseases 2013 13(Suppl 1):P13
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.6 - 5-year Impact Factor
1.283 - SNIP (Source Normalized Impact per Paper)
1.055 - SJR (SCImago Journal Rank)2022 Speed
6 days submission to first editorial decision for all manuscripts (Median)
154 days submission to accept (Median)2022 Usage
10,831,430 downloads
74,440 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication